Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro phagocytosis of collagens by immortalised human retinal Müller cells.
Ponsioen TL, van Luyn MJ, van der Worp RJ, Nolte IM, Hooymans JM, Los LI. Ponsioen TL, et al. Among authors: hooymans jm. Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):82-92. doi: 10.1007/s00417-006-0314-6. Epub 2006 Apr 6. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 16598463
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, Moll AC, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group. Vader MJC, et al. Among authors: hooymans jmm. Ophthalmol Retina. 2020 Aug;4(8):777-788. doi: 10.1016/j.oret.2020.02.008. Epub 2020 Feb 27. Ophthalmol Retina. 2020. PMID: 32362552 Free article. Clinical Trial.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: hooymans jmm. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial.
Buitendijk GHS, Schauwvlieghe AME, Vingerling JR, Schlingemann RO, Klaver CCW; comparing Bevacizumab to Ranibizumab in Age-related macular degeneration (BRAMD) Trial Research Group. Buitendijk GHS, et al. Am J Ophthalmol. 2018 Mar;187:130-137. doi: 10.1016/j.ajo.2018.01.003. Epub 2018 Jan 9. Am J Ophthalmol. 2018. PMID: 29330064 Clinical Trial.
Physico-chemistry of bacterial transmission versus adhesion.
Gusnaniar N, van der Mei HC, Qu W, Nuryastuti T, Hooymans JMM, Sjollema J, Busscher HJ. Gusnaniar N, et al. Among authors: hooymans jmm. Adv Colloid Interface Sci. 2017 Dec;250:15-24. doi: 10.1016/j.cis.2017.11.002. Epub 2017 Nov 5. Adv Colloid Interface Sci. 2017. PMID: 29129313 Free article. Review.
Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.
Schauwvlieghe AM, Dijkman G, Hooymans JM, Verbraak FD, Hoyng CB, Dijkgraaf MG, Peto T, Vingerling JR, Schlingemann RO. Schauwvlieghe AM, et al. Among authors: hooymans jm. PLoS One. 2016 May 20;11(5):e0153052. doi: 10.1371/journal.pone.0153052. eCollection 2016. PLoS One. 2016. PMID: 27203434 Free PMC article. Clinical Trial.
73 results